Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) Cost of Revenue (2020 - 2025)

Neuroone Medical Technologies (NMTC) has disclosed Cost of Revenue for 9 consecutive years, with $257082.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cost of Revenue rose 39.59% year-over-year to $257082.0, compared with a TTM value of $4.0 million through Dec 2025, up 118.25%, and an annual FY2025 reading of $4.0 million, up 66.7% over the prior year.
  • Cost of Revenue was $257082.0 for Q4 2025 at Neuroone Medical Technologies, down from $1.2 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $1.8 million in Q1 2025 and bottomed at $38462.0 in Q2 2022.
  • Average Cost of Revenue over 5 years is $424567.8, with a median of $220627.0 recorded in 2024.
  • The sharpest move saw Cost of Revenue skyrocketed 904.21% in 2023, then plummeted 76.06% in 2024.
  • Year by year, Cost of Revenue stood at $46844.0 in 2021, then soared by 170.87% to $126886.0 in 2022, then surged by 460.61% to $711335.0 in 2023, then plummeted by 74.11% to $184172.0 in 2024, then skyrocketed by 39.59% to $257082.0 in 2025.
  • Business Quant data shows Cost of Revenue for NMTC at $257082.0 in Q4 2025, $1.2 million in Q3 2025, and $781215.0 in Q2 2025.